Literature DB >> 28626080

Cyp2c44-mediated decrease of 15-HETE exacerbates pulmonary hypertension.

Gábor Á Fülöp1,2, Andriy Yabluchanskiy3,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28626080      PMCID： PMC5582927          DOI： 10.1152/ajpheart.00320.2017

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN： 0363-6135            Impact factor:   5.125


× No keyword cloud information.
  38 in total

1.  Glucose-6-phosphate dehydrogenase plays a critical role in hypoxia-induced CD133+ progenitor cells self-renewal and stimulates their accumulation in the lungs of pulmonary hypertensive rats.

Authors:  Sukrutha Chettimada; Sachindra Raj Joshi; Abdallah Alzoubi; Sarah A Gebb; Ivan F McMurtry; Rakhee Gupte; Sachin A Gupte
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-07-25       Impact factor: 5.464

2.  Potential role of mitochondrial superoxide decreasing ferrochelatase and heme in coronary artery soluble guanylate cyclase depletion by angiotensin II.

Authors:  Dhara Patel; Raed Alhawaj; Melissa R Kelly; John J O Accarino; Anand Lakhkar; Sachin A Gupte; Dong Sun; Michael S Wolin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-01       Impact factor: 4.733

3.  Reduced membrane cholesterol limits pulmonary endothelial Ca2+ entry after chronic hypoxia.

Authors:  Bojun Zhang; Jay S Naik; Nikki L Jernigan; Benjimen R Walker; Thomas C Resta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-31       Impact factor: 4.733

Review 4.  Pulmonary Hypertension.

Authors:  Marius M Hoeper; Hossein-Ardeschir Ghofrani; Ekkehard Grünig; Hans Klose; Horst Olschewski; Stephan Rosenkranz
Journal:  Dtsch Arztebl Int       Date:  2017-02-03       Impact factor: 5.594

5.  Ultrasound stimulates formation and release of vasoactive compounds in brain endothelial cells.

Authors:  Catherine M Davis; Azzdine Y Ammi; Nabil J Alkayed; Sanjiv Kaul
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-06-19       Impact factor: 4.733

6.  CYP2C44, a new murine CYP2C that metabolizes arachidonic acid to unique stereospecific products.

Authors:  Tracy C DeLozier; Cheng-Chung Tsao; Sherry J Coulter; Julie Foley; J Alyce Bradbury; Darryl C Zeldin; Joyce A Goldstein
Journal:  J Pharmacol Exp Ther       Date:  2004-04-14       Impact factor: 4.030

Review 7.  A global view of pulmonary hypertension.

Authors:  Marius M Hoeper; Marc Humbert; Rogerio Souza; Majdy Idrees; Steven M Kawut; Karen Sliwa-Hahnle; Zhi-Cheng Jing; J Simon R Gibbs
Journal:  Lancet Respir Med       Date:  2016-03-12       Impact factor: 30.700

8.  Cyp2c44 epoxygenase in the collecting duct is essential for the high K+ intake-induced antihypertensive effect.

Authors:  Wen-Hui Wang; Chengbiao Zhang; Dao-Hong Lin; Lijun Wang; Joan P Graves; Darryl C Zeldin; Jorge H Capdevila
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-25

9.  Tyrosine kinase inhibitor BIBF1000 does not hamper right ventricular pressure adaptation in rats.

Authors:  Michiel Alexander de Raaf; Franziska Elena Herrmann; Ingrid Schalij; Frances S de Man; Anton Vonk-Noordegraaf; Christophe Guignabert; Lutz Wollin; Harm Jan Bogaard
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-06-24       Impact factor: 4.733

10.  Oxidative stress in severe pulmonary hypertension.

Authors:  Rebecca Bowers; Carlyne Cool; Robert C Murphy; Rubin M Tuder; Matthew W Hopken; Sonia C Flores; Norbert F Voelkel
Journal:  Am J Respir Crit Care Med       Date:  2003-12-30       Impact factor: 21.405
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.